Can Patient‐Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Can Patient‐Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?

Published:2020-09-29 Issue:10 Volume:72 Page:1459-1465
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Ross Laura¹^ORCID,Stevens Wendy²,Wilson Michelle²,Strickland Gemma²,Walker Jennifer³,Sahhar Joanne⁴,Ngian Gene-Siew⁴,Roddy Janet⁵,Major Gabor⁶^ORCID,Proudman Susanna⁷,Baron Murray⁸,Nikpour Mandana¹

Affiliation:

1. St. Vincent’s Hospital Melbourne and the University of Melbourne Fitzroy Victoria Australia

2. St. Vincent’s Hospital Melbourne Fitzroy Victoria Australia

3. Flinders Medical Centre, Bedford Park, South Australia, Australia, and Royal Adelaide Hospital and Flinders University Adelaide South Australia Australia

4. Monash Health and Monash University Clayton Victoria Australia

5. Fiona Stanley Hospital Murdoch Western Australia Australia

6. Royal Newcastle Centre New Lambton Heights New South Wales Australia

7. Royal Adelaide Hospital and University of Adelaide Adelaide South Australia Australia

8. Sir Mortimer B. Davis Jewish General Hospital Montreal Quebec Canada

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24053

Reference23 articles.

1. The challenges and controversies of measuring disease activity in systemic sclerosis

2. Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis

3. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes

4. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index

5. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index;Arthritis & Rheumatology;2024-08-26

2. Heart involvement in systemic sclerosis: emerging concepts;Current Opinion in Rheumatology;2024-08-12

3. Performance of myotonometer in the assessment of skin involvement in systemic sclerosis;Clinical Rheumatology;2023-12-20

4. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review;RMD Open;2023-11

5. Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis;The Journal of Rheumatology;2022-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3